GlassScriptPhysician profile
Kiyanda Baldwin
NPI 1548419419
$7,773.75
in general payments reported to CMS, 2019-2025
21 companies · $92.32 in 2025
The $92.32 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $147 · 2020: $185 · 2021: $253 · 2022: $310 · 2023: $3,677 · 2024: $3,108 · 2025: $92.32.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $3,515 · Travel and Lodging: $2,719 · Food and Beverage: $644.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $3,515.12 |
| Travel and Lodging | $2,718.51 |
| Food and Beverage | $644.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $6,529.99 | 2019-2024 | Davinci Xi, Da Vinci Surgical System |
| Janssen Biotech, INC. | $278.70 | 2020-2021 | |
| Davol INC. | $185.32 | 2021-2025 | Phasix Mesh |
| Lifescan, INC. | $121.79 | 2022-2023 | |
| Medtronic, INC. | $98.98 | 2024 | Interstim |
| Lilly USA, LLC | $91.26 | 2022-2023 | Baqsimi, Lyumjev, Jardiance |
| Ibsa Pharma INC. | $86.76 | 2022-2023 | Tirosint, Licart |
| Monaghan Medical Corporation | $54.08 | 2024 | Aerochamber |
| Northgate Technologies, INC. | $39.60 | 2024 | Stimsite |
| Ethicon US, LLC | $39.47 | 2025 | Vistaseal, Ethicon, Stratafix |
| Amneal Pharmaceuticals LLC | $38.51 | 2022 | |
| Smith+Nephew, INC. | $34.16 | 2024-2025 | Collagenase Santyl, Pico 7 |
| Kerecis Limited | $32.56 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Abbott Laboratories | $24.92 | 2022 | |
| Astellas Pharma US INC | $20.70 | 2020 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axonics, INC. | $19.92 | 2024 | Axonics |
| Amgen INC. | $17.60 | 2022 | |
| Merck Sharp & Dohme LLC | $16.54 | 2020 | |
| Tandem Diabetes Care, INC. | $16.06 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $14.09 | 2023 | Gattex |
| Novo Nordisk INC | $12.74 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kiyanda Baldwin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.